Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma
Yamamoto, Shoma, Kato, Minoru, Takeyama, Yuji, Azuma, Yukari, Yukimatsu, Nao, Hirayama, Yukiyoshi, Otoshi, Taiyo, Yamasaki, Takeshi, Fujioka, Masaki, Gi, Min, Wanibuchi, Hideki, Uchida, Junji
Published in British journal of cancer (29.06.2023)
Published in British journal of cancer (29.06.2023)
Get full text
Journal Article
A retrospective study on optimal number of cycles of the first-line platinum-based chemotherapy for metastatic urothelial carcinoma
Yamamoto, Shoma, Kato, Minoru, Takeyama, Yuji, Yukimatsu, Nao, Hirayama, Yukiyoshi, Otoshi, Taiyo, Yamasaki, Takeshi, Kuratsukuri, Katsuyuki, Uchida, Junji
Published in Urologic oncology (01.05.2022)
Published in Urologic oncology (01.05.2022)
Get full text
Journal Article
Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma
Takeyama, Yuji, Kato, Minoru, Nishihara, Chikako, Yamasaki, Takeshi, Iguchi, Taro, Tamada, Satoshi, Kuratsukuri, Katsuyuki, Nakatani, Tatsuya
Published in International journal of clinical oncology (01.10.2018)
Published in International journal of clinical oncology (01.10.2018)
Get full text
Journal Article
Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
Shimizu, Yasuomi, Tamada, Satoshi, Kato, Minoru, Hirayama, Yukiyoshi, Takeyama, Yuji, Iguchi, Taro, Sadar, Marianne D, Nakatani, Tatsuya
Published in Journal of clinical medicine (16.11.2018)
Published in Journal of clinical medicine (16.11.2018)
Get full text
Journal Article
Steroid sulfatase promotes invasion through epithelial-mesenchymal transition and predicts the progression of bladder cancer
Shimizu, Yasuomi, Tamada, Satoshi, Kato, Minoru, Takeyama, Yuji, Fujioka, Masaki, Kakehashi, Anna, Nakatani, Tatsuya, Wanibuchi, Hideki, Gi, Min
Published in Experimental and therapeutic medicine (01.12.2018)
Published in Experimental and therapeutic medicine (01.12.2018)
Get full text
Journal Article
Trends over time in the proportion of sequential treatment and overall survival in patients with metastatic urothelial carcinoma in real-world practice
Yamamoto, Shoma, Kato, MInoru, Matsue, Taisuke, Yukimatsu, Nao, Takeyama, Yuji, Otoshi, Taiyo, Yamasaki, Takeshi, Kuratsukuri, Katsuyuki, Uchida, Junji
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Trend in overall survival from the start of first-line chemotherapy in patients with metastatic urothelial carcinoma
Yamamoto, Shoma, Kato, Minoru, Matsue, Taisuke, Yukimatsu, Nao, Takeyama, Yuji, Otoshi, Taiyo, Yamasaki, Takeshi, Kuratsukuri, Katsuyuki, Uchida, Junji
Published in Japanese journal of clinical oncology (07.02.2024)
Published in Japanese journal of clinical oncology (07.02.2024)
Get full text
Journal Article
Investigation of eligibility for adjuvant therapy from real-world data of patients with urothelial carcinoma undergoing radical cystectomy and radical nephroureterectomy
Matsue, Taisuke, Kato, Minoru, Kosugi, Yuki, Ishizaki, Kota, Masuda, Hiroo, Yamamoto, Shoma, Takeyama, Yuji, Yukimatsu, Nao, Otoshi, Taiyo, Yamasaki, Takeshi, Kuratsukuri, Katsuyuki, Uchida, Junji
Published in Japanese journal of clinical oncology (07.02.2024)
Published in Japanese journal of clinical oncology (07.02.2024)
Get full text
Journal Article
The effect of androgen receptor splice variant 7 on the growth of castration-resistant prostate cancer and the efficacy of taxane chemotherapy
Shimizu, Yasuomi, Kato, Minoru, Takeyama, Yuji, Hamada, Kosuke, Iguchi, Taro, Tamada, Satoshi, Nakatani, Tatsuya
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Development of myeloid-derived suppressor cells (MDSC) targeted therapy for the treatment of cisplatin-resistant bladder cancer
Takeyama, Yuji, Kato, Minoru, Shimizu, Yasuomi, Hamada, Kosuke, Iguchi, Taro, Tamada, Satoshi, Nakatani, Tatsuya
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: A retrospective study
Hamada, Kosuke, Iguchi, Taro, Tamada, Satoshi, Kato, Minoru, Yamasaki, Takeshi, Takeyama, Yuji, Shimizu, Yasuomi, Yasuda, Sayaka, Nakatani, Tatsuya
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
MP57-06 MANAGEMENT OF ENZALUTAMIDE-RELATED ADVERSE EVENTS FOR CRPC PATIENTS BY USING PATIENT REPORTED OUTCOMES LEADS BETTER PROGNOSIS
Iguchi, Taro, Yasuda, Sayaka, Kato, Minoru, Yamasaki, Takeshi, Shimizu, Yasuomi, Takeyama, Yuji, Tamada, Satoshi, Nakatani, Tatsuya
Published in The Journal of urology (01.04.2017)
Published in The Journal of urology (01.04.2017)
Get full text
Journal Article
Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer
Takeyama, Yuji, Kato, Minoru, Tamada, Satoshi, Azuma, Yukari, Shimizu, Yasuomi, Iguchi, Taro, Yamasaki, Takeshi, Gi, Min, Wanibuchi, Hideki, Nakatani, Tatsuya
Published in Cancer letters (01.06.2020)
Published in Cancer letters (01.06.2020)
Get full text
Journal Article